Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06431373
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-05-22
Brief Title:
A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis
Sponsor:
Priovant Therapeutics Inc
Organization:
Priovant Therapeutics Inc
Study Overview
Official Title:
A Phase 3 Randomized Double-Masked Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Active Non-Infectious Intermediate- Posterior- and Panuveitis
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CLARITY
Brief Summary:
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active non-anterior intermediate posterior or pan non-infectious uveitis NIU
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None